V 2 C MXene Nanozyme Attenuates Sepsis‐Induced Gut Injury via Paneth Cell Death and ER Stress Regulation
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von He-Ping Zuo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Internal Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Sepsis, Endoplasmic Reticulum Stress, Paneth Cells. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, Anhui Provincial Institute of Translational Medicine, Anhui Provincial Department of Science and Technology.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis‐associated intestinal injury represents a critical pathological event contributing to multiple organ dysfunction, with its pathogenesis closely linked to excessive oxidative stress and hyperactivated endoplasmic reticulum stress. Current clinical interventions lack the capacity for precise modulation of the intestinal microenvironment, while existing nanozyme systems generally face challenges such as low oral delivery efficiency, insufficient stability, and uncertain biosafety. To address these limitations, we developed a novel oral nanozyme delivery system based on 2D V 2 C MXene. Through surface modification with hydroxyethyl cellulose (HEC), we constructed a V 2 C@HEC (CV) nanozyme with enhanced physiological stability and intestinal mucoadhesion. In both in vitro and in vivo studies, the CV nanozyme demonstrated significant reactive oxygen species (ROS)‐scavenging capacity. Oral administration of CV effectively mitigated intestinal barrier damage and improved survival in a septic mouse model. Mechanistic investigations suggested that the protective effects of CV may be associated with ROS clearance and modulation of endoplasmic reticulum stress, with inhibition of the ATF6/CHOP signaling pathway potentially serving as one underlying mechanism for its cytoprotective function. In summary, this study not only presents a novel nanozyme material with favorable biocompatibility, excellent stability, and a defined antioxidant mechanism, but also provides an innovative materials‐based strategy for the treatment of sepsis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Internal Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
- Liver Transplant Center & Laboratory of Liver Transplantation, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- The Second Department of Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
ORCID-Profile: He-Ping Zuo
Förderung
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Anhui Provincial Institute of Translational Medicine
- Anhui Provincial Department of Science and Technology
- Health Commission of Anhui Province
- Anhui Provincial Natural Science Foundation
- National Natural Science Foundation of China
- National Natural Resources Fund
- Sichuan Natural Science Foundation
Zitieren
APA
Zuo, H. P., Yang, J., Zhao, W., & Yang, M. (2026). V 2 C MXene Nanozyme Attenuates Sepsis‐Induced Gut Injury via Paneth Cell Death and ER Stress Regulation. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71041
Vancouver
Zuo HP, Yang J, Zhao W, Yang M. V 2 C MXene Nanozyme Attenuates Sepsis‐Induced Gut Injury via Paneth Cell Death and ER Stress Regulation. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71041
BibTeX
@article{Zuo2026,
author = {Zuo, He-Ping and Yang, Jia and Zhao, Wei and Yang, Min},
title = {V 2 C MXene Nanozyme Attenuates Sepsis‐Induced Gut Injury via Paneth Cell Death and ER Stress Regulation},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71041}
}
EUVIMED